FDA Inspection 897316 — Acella Pharmaceuticals, LLC
The FDA completed an inspection of Acella Pharmaceuticals, LLC on September 10, 2014 in Alpharetta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 10, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Alpharetta, GA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)